Astrana Health ASTH Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by Astrana Health in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Astrana Health's amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Astrana Health's amortization expense related to capitalized debt issuance costs?
- Astrana Health (ASTH) reported amortization expense related to capitalized debt issuance costs of $1.13M in Q1 2026.
- How has Astrana Health's amortization expense related to capitalized debt issuance costs changed year-over-year?
- Astrana Health's amortization expense related to capitalized debt issuance costs increased by 64.1% year-over-year, from $691K to $1.13M.
- What is the long-term trend for Astrana Health's amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), Astrana Health's amortization expense related to capitalized debt issuance costs has grown at a 39.2% compound annual growth rate (CAGR), from $1.08M to $4.05M.